CAPR vs CHRW · $1.62B cap vs P/E 37, rev $8.95B
Capricor Therapeutics Inc (CAPR) versus CH Robinson Worldwide Inc (CHRW) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported CHRW revenue for 2026-06-30 was $8.95B. Net income was $334.0M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
CAPR currently screens at market cap $1.62B. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Not investment advice. Open the CAPR and CHRW stock pages for the full models.
Not investment advice.